Marco Baia

Surgical oncologist, retroperitoneal & soft tissue sarcoma, GIST, desmoid tumor @IstTumori Milan - Italy @ChirSarcomi_INT

[Italian Sarcoma Group @ItaSarcomaGroup]

Su @AboutPharmaHPS il contributo di Viviana Appolloni, (Trial Center Italian Sarcoma Group), Fatima Tizi e Celeste Cagnazzo.
https://t.co/bYVo1Q2HFE

[Marco Fiore, MD, FACS, FEBSh @FioreDoc]

Interested in #RetroperitonealSarcoma surgery?
Join #ReSurge2026, the @ESSOnews online course endorsed by @TARPSWG community.

@alegronchi @FioreDoc #CarolJSwallow #DirkStrauss

Register here: https://t.co/ZGhmLWeojk @IstTumori @SinaiHealth

[Dario Callegaro @DCalleMD]

The XXIX Annual Meeting of the Italian Sarcoma Group kicks off in Palermo 🇮🇹

250 attendees gathered to share science, collaboration, and new ideas in #sarcoma care. Looking forward to inspiring discussions over the next days! @ItaSarcomaGroup @SilviaStacchia @annamariafrezza

[Alessandro Gronchi @alegronchi]

1/ 🚨 When surgery is not enough: time to rethink patient selection in #retroperitoneal #sarcoma. Are we operating on tumor biology we don’t yet understand?
In primary RPS, ~20% of patients recur within 6 months after surgery — with survival comparable to unresected patients.

[Alessandro Gronchi @alegronchi]

1/4 @AnnSurgOncol
What can we learn from 20 years of treating primary #retroperitoneal #sarcoma?
Analysis of 872 consecutive patients shows a significant improvement in overall survival over time. @ctosociety @SocSurgOnc @ctosociety @IstTumori
https://t.co/ijNRgKucdO

[Marco Baia @MBaiaDoc]

@XavierBerardMD Great job! We started to use aortic criopreserved homograft over PTFE in the last years to reconstruct IVC. You leave the patient on anticoagulants life-long with venous PTFE graft?

[nwsarcoma @nwsarcoma]

Today is national #Leiomyosarcomaday and we stand with those who fight this rare disease. For more information on leiomyosarcoma, check out UCLA's research updates and education material here: https://t.co/x0RQelXMOp

[Alessandro Gronchi @alegronchi]

In Lyon for the WHO meeting to update the classification of soft tissue & bone sarcomas.
A crucial step for diagnostics, research, and care in these rare tumors.
Proud to contribute to this global effort.
#Sarcoma #WHO #RareCancers #Pathology #Lyon2025 @ctosociety

[Italian Sarcoma Group @ItaSarcomaGroup]

🎗 July is #Sarcoma Awareness Month! At the Italian Sarcoma Group, we’re committed every day to advancing research, improving care and standing by patients and families.
Together, we fight rare cancers. 💛
#SarcomaAwareness #SarcomaStrong #ISG #RareButResilient

[Marco Baia @MBaiaDoc]

@fdossa @radaste @DCalleMD @aleborghiMD @sandro_pasquali @Robertasanfili @FioreDoc @alegronchi

[Marco Baia @MBaiaDoc]

Our flagship #left #retroperitoneal #liposarcoma procedure developed @ChirSarcomi_INT @IstTumori

Surgical 📹 illustrating our flagship technique in 6 reproducible stages on @AnnSurgOncol

https://t.co/N7Krrc2R9Q…

@SocSurgOnc @ESSOnews @oncoteamsarcoma @TARPSWG @ctosociety

[Chordoma Foundation @ChordomaFDN]

More than 140 experts from around the world came together last week to work toward improving the standard of care for chordoma via upcoming updated consensus guidelines -- a remarkable effort. Grateful to @alegronchi, @AOSpine & all who participated!

[Alessandro Gronchi @alegronchi]

Il bando per la selezione di 3 felllow di chirurgia oncologica è fuori! Affrettatevi! https://t.co/HSBse4lvup

[SICO Sarcoma Social @oncoteamsarcoma]

🔎 Demicco Score in Solitary Fibrous Tumors (SFT):
A practical, pathology-based tool to assess metastatic risk in primary SFTs.
3-variable (2012): Size, Mitoses, Age
4-variable (2017): + Necrosis
🧠 Do you use it in your practice? #Sarcoma #SFT #OncoPath

[SICO Sarcoma Social @oncoteamsarcoma]

‼️ Welcome to our 2nd Journal Club post

🏥🔪Today: Surgical technique for right-sided RPS

⁉️What does it take to achieve complete en bloc resection? Every step tests skill & precision.

🔗 https://t.co/FS0p6ZuMzy

[SICO Sarcoma Social @oncoteamsarcoma]

🔵 New month, new topic!
In this case we walk through the management of a Left RPS, from preop to multivisceral resection.
Why does it matter? Because in sarcomas, the first treatment makes the difference.

👇Have you ever faced such a case? Share your thoughts below!
#Sarcoma

[SICO Sarcoma Social @oncoteamsarcoma]

🔪 How do you remove a left retroperitoneal liposarcoma?
It’s not just #resection. It’s #strategy, standardization and knowing when (and why) to take surrounding organs.

Step-by-step #sarcomasurgery 👇
🔗https://t.co/czA65FJhuk
#SICOSarcomaSocial #SurgicalEducation

[SICO Sarcoma Social @oncoteamsarcoma]

New from SICO Sarcoma Social & @TARPSWG:

@FioreDoc on margins,
@Dirk_Strauss on the left-sided approach,
@GladdyLab on histology-driven resection.

🧐Real surgeons, real strategy.

Full video: https://t.co/dfodvUVCdO

[SICO Sarcoma Social @oncoteamsarcoma]

New Q&A session!
All answers are evidence-based!
Must-read papers:

🔗https://t.co/mAsxibLRlJ

🔗https://t.co/XW3hkA5IPF

🔗 https://t.co/czA65FJhuk

[SICO Sarcoma Social @oncoteamsarcoma]

@IEOufficiale @ElisabettaPenn1 @SaraCop3 @SICOBoard